| Authors: |
Geoerger B; Gustave Roussy Cancer Center, Department of Pediatric and Adolescent Oncology, Université Paris-Saclay, Villejuif, France. Electronic address: birgit.geoerger@gustaveroussy.fr., Zwaan CM; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands; Princess Máxima Center, Utrecht, Netherlands., Marshall LV; Paediatric and Adolescent Oncology Drug Development Unit, The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK., Michon J; Service de Pédiatrie, SIREDO Center, Curie Institute, Paris, France., Bourdeaut F; Service de Pédiatrie, SIREDO Center, Curie Institute, Paris, France., Casanova M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Corradini N; Haematology and Oncology Paediatric Institut, Léon Bérard Centre, Lyon, France., Rossato G; F Hoffmann-La Roche, Basel, Switzerland., Farid-Kapadia M; F Hoffmann-La Roche, Mississauga, Canada., Shemesh CS; Genentech, San Francisco, CA, USA., Hutchinson KE; Genentech, San Francisco, CA, USA., Donaldson F; F Hoffmann-La Roche, Welwyn, UK., Liao M; Genentech, San Francisco, CA, USA., Caron H; F Hoffmann-La Roche, Basel, Switzerland., Trippett T; Memorial Sloan Kettering Cancer Center, New York, NY, USA. |
